Relationship between blood metals and inflammation in taxi drivers

Carregando...
Imagem de Miniatura
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2015
Editora
ELSEVIER SCIENCE BV
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
BRUCKER, Natalia
MORO, Angela
CHARAO, Mariele
BUBOLS, Guilherme
NASCIMENTO, Sabrina
GOETHEL, Gabriela
BARTH, Anelise
PROHMANN, Ana C.
ROCHA, Rafael
MORESCO, Rafael
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CLINICA CHIMICA ACTA, v.444, p.176-181, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Cardiovascular disease is a cause of concern in public health worldwide, reinforcing the need for studies related to the identification of potential agents that contribute to the inflammation process and atherosclerosis. This study aimed to evaluate whether metals are associated with inflammatory and kidney damage and could contribute to the atherosclerosis process. Methods: Blood metals, inflammatory markers, homocysteine, antioxidants and renal markers were measured in 42 taxi drivers and 27 controls (non-occupationally exposed). Results: Taxi drivers had increased Hg, As, Pb and Cd levels, however Cu and Zn levels were decreased compared to controls (p < 0.05). Hg, As and Pb levels were positively associated with pro-inflammatory cytokines, nitric oxide and negatively associated with glutathione peroxidase. Moreover, Hg, As and Pb presented positive associations with homocysteine, an independent risk factor for atherosclerosis. Regarding markers of kidney function, N-acetyl-beta-D-glucosaminidase levels were increased in taxi drivers and correlated to inflammation markers. Conclusion: Hg levels were found above the recommended limits in taxi drivers and both Hg and As levels showed associations with inflammatory process, oxidative status and homocysteine. Thus, chemical substances as Hg and As can be considered as additional contributors to the development of cardiovascular diseases.
Palavras-chave
Toxic metals, Inflammation markers, Homocysteine, Occupational exposure
Referências
  1. Al Bakheet SA, 2013, ENVIRON POLLUT, V181, P226, DOI 10.1016/j.envpol.2013.06.014
  2. Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.28836
  3. Bellinger DC, 2008, BASIC CLIN PHARMACOL, V102, P237, DOI 10.1111/j.1742-7843.2007.00164.x
  4. Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9
  5. Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf
  6. Burgaz S, 2002, CHEMOSPHERE, V47, P57, DOI 10.1016/S0045-6535(01)00185-0
  7. Burtis CA, 2008, TEITZ FUNDAMENTOS CL, V6th
  8. Charao MF, 2012, J BRAZIL CHEM SOC, V23, P1441, DOI 10.1590/S0103-50532012005000001
  9. Ciarrocca M, 2013, CHEMOSPHERE, V90, P2077, DOI 10.1016/j.chemosphere.2012.10.060
  10. Dangleben NL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-73
  11. de Miranda RM, 2012, AIR QUAL ATMOS HLTH, V5, P63, DOI 10.1007/s11869-010-0124-1
  12. Delfino RJ, 2011, AIR QUAL ATMOS HLTH, V4, P37, DOI 10.1007/s11869-010-0095-2
  13. Grass DS, 2010, ENVIRON RES, V110, P1, DOI 10.1016/j.envres.2009.10.006
  14. Hambach R, 2013, TOXICOL LETT, V222, P233, DOI 10.1016/j.toxlet.2013.06.218
  15. Hartikainen H, 2005, J TRACE ELEM MED BIO, V18, P309, DOI 10.1016/j.jtemb.2005.02.009
  16. Hennig B, 2012, ENVIRON HEALTH PERSP, V120, P771, DOI 10.1289/ehp.1104712
  17. Hennig B, 2007, NUTR METAB CARDIOVAS, V17, P162, DOI 10.1016/j.numecd.2006.01.003
  18. Huang HB, 2013, CANCER EPIDEM BIOMAR, V22, P102, DOI 10.1158/1055-9965.EPI-12-0706
  19. Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032
  20. Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012
  21. Kelly FJ, 2004, P NUTR SOC, V63, P579, DOI 10.1079/PNS2004388
  22. Knibbs LD, 2012, ENVIRON INT, V49, P110, DOI 10.1016/j.envint.2012.08.013
  23. Kordas K, 2010, SCI TOTAL ENVIRON, V408, P4488, DOI 10.1016/j.scitotenv.2010.06.041
  24. Kuno R, 2013, INT J HYG ENVIR HEAL, V216, P243, DOI 10.1016/j.ijheh.2012.05.010
  25. Lai CH, 2005, OCCUP ENVIRON MED, V62, P216, DOI 10.1136/oem.2004.015107
  26. Li HM, 2013, SCI TOTAL ENVIRON, V456, P212, DOI 10.1016/j.scitotenv.2013.03.094
  27. MARUHN D, 1976, CLIN CHIM ACTA, V73, P453, DOI 10.1016/0009-8981(76)90147-9
  28. Mateus VL, 2013, SPECTROCHIM ACTA B, V86, P5
  29. Mortada WI, 2001, AM J NEPHROL, V21, P274, DOI 10.1159/000046261
  30. Motts JA, 2014, ENVIRON RES, V132, P12, DOI 10.1016/j.envres.2014.03.024
  31. Nascimento SN, 2015, ENVIRON RES, V136, P387
  32. Ojo JO, 2014, ENVIRON SCI POLLUT R, V21, P1124, DOI 10.1007/s11356-013-1951-z
  33. Olsen L, 2012, INT J HYG ENVIR HEAL, V215, P411, DOI 10.1016/j.ijheh.2011.11.004
  34. PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
  35. Rambouskova J, 2013, ARCH GERONTOL GERIAT, V56, P389, DOI 10.1016/j.archger.2012.11.002
  36. Reyes JL, 2013, BIOMED RES INT, DOI 10.1155/2013/730789
  37. Schulte PA, 2012, TOXICOL LETT, V213, P91, DOI 10.1016/j.toxlet.2011.03.027
  38. Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3
  39. Silbergeld Ellen K, 2005, Toxicol Appl Pharmacol, V207, P282, DOI 10.1016/j.taap.2004.11.035
  40. Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332
  41. Tatsch E, 2011, CLIN BIOCHEM, V44, P348, DOI 10.1016/j.clinbiochem.2010.12.011
  42. Tchounwou PB, 2004, MOL CELL BIOCHEM, V255, P47, DOI 10.1023/B:MCBI.0000007260.32981.b9
  43. Thron RW, 1996, OTOLARYNG HEAD NECK, V114, P281, DOI 10.1016/S0194-5998(96)70184-5
  44. Traversi D, 2010, J ENVIRON MONITOR, V12, P484, DOI 10.1039/b913314c
  45. Valavanidis A, 2005, REDOX REP, V10, P37, DOI 10.1179/135100005X21606
  46. Vestra MD, 2005, J AM SOC NEPHROL S1, V16, pS78, DOI 10.1681/ASN.2004110961
  47. Wang GS, 2008, TOXICOL APPL PHARM, V233, P92, DOI 10.1016/j.taap.2008.01.017
  48. WHO, 1996, TRAC EL HUM NUTR HLT
  49. Wu MM, 2003, ENVIRON HEALTH PERSP, V111, P1429, DOI 10.1289/txg.6396